External broker reports(aggregated public sources), HDFC Securities

HDFC Securities

External broker reports(aggregated public sources)

HDFC securities is the best online trading platform for stocks, IPOs, mutual fund in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Thematic (Sector/Industry)

<ul><li>Dr Reddy’s Laboratories: EBITDA grew (14% YoY) as +13% YoY sales growth (-3% QoQ US, +5% YoY in EU, +9% YoY EMs, and +34% YoY in RoW, India declined 12% YoY, adjusted growth was at 11%), steady gross margin (+65 bps YoY) and muted staff cost were offset by higher R&amp;D/SG&amp;A (+28/+22% YoY)</li><li>DRRD expects to sustain growth in the US over the next few years with steady traction in gRevlimid and new launches (20+ launches p.a for the next few years)</li><li>The company expects India to see steady growth in FY25, led by new launches, scale-up in key therapies, and in-licensing opportunities</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Dr Reddy’s Laboratories: EBITDA grew (14% YoY) as +13% YoY sales growth (-3% QoQ US, +5% YoY in EU, +9% YoY EMs, and +34% YoY in RoW, India declined 12% YoY, adjusted growth was at 11%), steady gross margin (+65 bps YoY) and muted staff cost were offset by higher R&amp;D/SG&amp;A (+28/+22% YoY)DRRD expects to sustain growth in the US over the next few years with steady traction in gRevlimid and new launches (20+ launches p.a for the next few years)The company expects India to see steady growth in FY25, led by new launches, scale-up in key therapies, and in-licensing opportunitiesContent is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

HSIE Results Daily: Dr Reddy’s Laboratories, Lupin, IRB Infra, Max Financial

SGX Market Strategist, Equity & Fixed Income, Singapore Exchange Ltd (SGX)

Geoff Howie

SGX Market Strategist, Equity & Fixed Income

Asia’s leading multi-asset exchange

Singapore Exchange Ltd (SGX)

Singapore Exchange is Asia’s leading and trusted market infrastructure, facilitating the exchange of capital and ideas to create value for people, businesses and economies. As a multi-asset exchange operating equity, fixed income and derivatives markets to the highest regulatory standards, SGX is a vertically integrated business that provides listing, trading, clearing, settlement, depository and data services.

With about 40% of listed companies and over 80% of listed bonds originating outside of Singapore as well as established linkages across the region and in Europe, SGX is Asia’s most international and connected exchange. Offering a full suite of derivatives products across Asian equity indices, commodities and currencies, SGX is the world’s most liquid international market for the benchmark equity indices of China, India, Japan and ASEAN.

As Asia’s pioneering central counterparty, SGX is globally recognised for its risk management and clearing capabilities, and was one of the first globally to adopt the Principles for Financial Market Infrastructure.

Headquartered in AAA-rated Singapore, SGX has over 800 employees including offices in Beijing, Chicago, Hong Kong, London, New York, Mumbai, San Francisco, Shanghai and Tokyo.

Equity Bottom-Up

<ul><li>Over five sessions, 32 director/CEO acquisitions and 11 disposals were reported, with 27 companies conducting buybacks totaling S$37 million.</li><li>Aspial Lifestyle's Chairman acquired 1,331,200 shares, increasing direct interest to 9.95%, following a S$46.4 million acquisition.</li><li>iWOW Technology announced a proposed placement of 66.7 million shares at S$0.225 each, raising up to S$15 million.</li></ul>

Over five sessions, 32 director/CEO acquisitions and 11 disposals were reported, with 27 companies conducting buybacks totaling S$37 million.Aspial Lifestyle's Chairman acquired 1,331,200 shares, increasing direct interest to 9.95%, following a S$46.4 million acquisition.iWOW Technology announced a proposed placement of 66.7 million shares at S$0.225 each, raising up to S$15 million.

The Week of Insider Buying and Buyback Activity

<ul><li>Over five sessions to 25 June, directors and CEOs reported 21 acquisitions and five disposals across 30 primary-listed stocks.</li><li>Soon Hock Enterprise's Executive Chairman increased his direct interest to 73.32% with a purchase of 2,033,000 shares.</li><li>Lum Chang Creations entered a placement agreement for up to 35 million shares, raising up to S$11.4 million.</li></ul>

Over five sessions to 25 June, directors and CEOs reported 21 acquisitions and five disposals across 30 primary-listed stocks.Soon Hock Enterprise's Executive Chairman increased his direct interest to 73.32% with a purchase of 2,033,000 shares.Lum Chang Creations entered a placement agreement for up to 35 million shares, raising up to S$11.4 million.

Director Accumulation Extends Across Established and Newly Listed Counters

<ul><li>Singapore Telecommunications led buybacks with 27.1 million shares at S$4.26, part of a S$2 billion programme.</li><li>Embracing Future Holdings' Chen Lu increased stake to 9.17% with 83 million shares for S$3.9 million.</li><li>Amova Asset Management Asia raised Frencken stake to 6.03%, coinciding with FY26 revenue and profit expectations.</li></ul>

Singapore Telecommunications led buybacks with 27.1 million shares at S$4.26, part of a S$2 billion programme.Embracing Future Holdings' Chen Lu increased stake to 9.17% with 83 million shares for S$3.9 million.Amova Asset Management Asia raised Frencken stake to 6.03%, coinciding with FY26 revenue and profit expectations.

Buyback Momentum Continues, Director Acquisitions Broaden

<ul><li>Singapore Telecommunications led buybacks with 13.3 million shares at S$4.33 under a S$2 billion programme.</li><li>Ho Bee Holdings acquired 334,700 shares, raising Chua Thian Poh’s deemed interest from 75.737% to 75.788%.</li><li>Nam Cheong's 1QFY26 PATMI increased 160% to RM78.9 million, with net gearing reduced to 0.17 times.</li></ul>

Singapore Telecommunications led buybacks with 13.3 million shares at S$4.33 under a S$2 billion programme.Ho Bee Holdings acquired 334,700 shares, raising Chua Thian Poh’s deemed interest from 75.737% to 75.788%.Nam Cheong's 1QFY26 PATMI increased 160% to RM78.9 million, with net gearing reduced to 0.17 times.

Ho Bee chair ups stake; M&G becomes substantial unitholder in NetLink NBN Trust

Singapore

Aspial Lifestyle is a Singapore-based investment holding company primarily engaged in pawnbroking, money lending, and the retail and trading of jewellery and branded merchandise. The company offers jewellery under brands such as Lee Hwa Jewellery, Goldheart Jewelry, and Niessing, and provides pawnbroking services through Maxi-Cash and Dr. Pajak. It also has interests in secured lending and property rental. The company was incorporated in 2008 and is headquartered in Singapore.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aspial Lifestyle (ASPL SP)

HSIE Results Daily: Dr Reddy’s Laboratories, Lupin, IRB Infra, Max Financial

DRRD expects to sustain growth in the US over the next few years with steady traction in gRevlimid and new launches (20+ launches p.a for the next...

HDFC Securities

The Week of Insider Buying and Buyback Activity

Over five sessions, 32 director/CEO acquisitions and 11 disposals were reported, with 27 companies conducting buybacks totaling S$37...

Singapore Exchange Ltd (SGX)

Director Accumulation Extends Across Established and Newly Listed Counters

Over five sessions to 25 June, directors and CEOs reported 21 acquisitions and five disposals across 30 primary-listed stocks. Soon Hock...

Singapore Exchange Ltd (SGX)

Buyback Momentum Continues, Director Acquisitions Broaden

Singapore Telecommunications led buybacks with 27.1 million shares at S$4.26, part of a S$2 billion programme. Embracing Future Holdings' Chen Lu...

Singapore Exchange Ltd (SGX)

Ho Bee chair ups stake; M&G becomes substantial unitholder in NetLink NBN Trust

Singapore Telecommunications led buybacks with 13.3 million shares at S$4.33 under a S$2 billion programme. Ho Bee Holdings acquired 334,700...

Singapore Exchange Ltd (SGX)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)